Screening of biochemical/histological changes associated to C6 glioma tumor development by FTIR/PCA imaging.

Principal components analysis (PCA) combined to Fourier transform infrared (FTIR) microspectroscopic imaging was used to screen biochemical changes associated to C6 glioma tumor from 7 to 19 days growth. Normal brain and tumor obtained at 7, 12, 19 days after C6 cell injection were used to develop a diagnostic model of brain glioma based on PCA analysis. This classification model was validated using extra-measurements on normal and tumor at 9 and 15 days post-implantation. The spatial and biochemical information obtained from FTIR/PCA maps can be used to improve the discrimination between normal and grading human glioma. The first 4 PCs which account for more than 93.6% of total spectral variance were used to construct pseudo-color scores maps and compared each map to the corresponding hematoxylin and eosin (H&E) staining. Our results reported that by correlating pseudocolor map scores with H&E staining it was possible to screen histological changes associated with tissue transformation. In fact, PC1 and PC4 were associated to the tumor, surrounding tumor and necrosis. Indeed, at day 7 after tumor implantation, FTIR investigations displayed a very small abnormal zone associated with the proliferation of C6 cells in the caudate putamen (CP). PC2 and PC3 described normal brain structures such as white matter (corpus callosum (CC) and commissura anterior (CA)) and some cortex layers (grey matter). After delipidation of the tissues, we were still able to differentiate between different tissue features based on nucleic acid and protein content. By comparing the patterns of the PC loads with the spectra of lipids extracted from white and gray matters, and DNA, we have identified some biochemical changes associated with tissue transformation. This work demonstrated that our classification model provides a successful histological classification of different brain structures.

[1]  Desensitization of the nicotinic acetylcholine receptor mainly involves a structural change in solvent-accessible regions of the polypeptide backbone. , 1997, Biochemistry.

[2]  L. Loeb,et al.  8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions. , 1992, The Journal of biological chemistry.

[3]  Tormod Næs,et al.  Related versions of the multiplicative scatter correction method for preprocessing spectroscopic data , 1995 .

[4]  E. Hogan,et al.  Branched monosialo gangliosides of the lacto-series isolated from bovine erythrocytes: characterization of a novel ganglioside, NeuGc-isooctaosylceramide. , 1994, Archives of biochemistry and biophysics.

[5]  R. Burwell Borders and cytoarchitecture of the perirhinal and postrhinal cortices in the rat , 2001, The Journal of comparative neurology.

[6]  Bert Grobben,et al.  Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion , 2002, Cell and Tissue Research.

[7]  Abdelilah Beljebbar,et al.  Modeling and quantifying biochemical changes in C6 tumor gliomas by Fourier transform infrared imaging. , 2008, Analytical chemistry.

[8]  Ian T. Jolliffe,et al.  Principal Component Analysis , 2002, International Encyclopedia of Statistical Science.

[9]  Jing Wang,et al.  FT-IR spectroscopic analysis of normal and cancerous tissues of esophagus. , 2003, World journal of gastroenterology.

[10]  Paul Geladi,et al.  Principal Component Analysis , 1987, Comprehensive Chemometrics.

[11]  M. Teh,et al.  Diagnostic potential of near-infrared Raman spectroscopy in the stomach: differentiating dysplasia from normal tissue , 2008, British Journal of Cancer.

[12]  N. Polissar,et al.  Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Gabriele Schackert,et al.  Distinguishing and grading human gliomas by IR spectroscopy. , 2003, Biopolymers.

[14]  Abdelilah Beljebbar,et al.  Brain tissue characterisation by infrared imaging in a rat glioma model. , 2006, Biochimica et biophysica acta.

[15]  H. Barr,et al.  Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus , 2006, British Journal of Cancer.

[16]  J. Cairncross,et al.  Chemotherapy for brain tumors. , 1998, Oncology.

[17]  Chris W. Brown,et al.  Screening Pap Smears with Near-Infrared Spectroscopy , 1995 .

[18]  M. R. Mickey,et al.  Estimation of Error Rates in Discriminant Analysis , 1968 .

[19]  A. Mahadevan-Jansen,et al.  Near‐Infrared Raman Spectroscopy for In Vitro Detection of Cervical Precancers , 1998 .

[20]  K.M. O'Brien,et al.  Development and evaluation of spectral classification algorithms for fluorescence guided laser angioplasty , 1989, IEEE Transactions on Biomedical Engineering.

[21]  Martin J. Snowden,et al.  A comparison of Raman chemical images produced by univariate and multivariate data processing—a simulation with an example from pharmaceutical practice , 2004 .

[22]  R. Bjerkvig,et al.  Invasiveness of primary brain tumors , 2004, Cancer and Metastasis Reviews.

[23]  Christoph Krafft,et al.  Classification of malignant gliomas by infrared spectroscopic imaging and linear discriminant analysis , 2007, Analytical and bioanalytical chemistry.

[24]  A. A. Spector,et al.  The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue , 1996, Lipids.

[25]  O. Fedorov,et al.  Estimation of amino acid residue side‐chain absorption in the infrared spectra of protein solutions in heavy water , 1975, Biopolymers.

[26]  H. Hirschberg ENDOTHELIAL GROWTH FACTOR PRODUCTION IN CULTURES OF HUMAN GLIOMA CELLS , 1984, Neuropathology and applied neurobiology.

[27]  Wei Zheng,et al.  Classification of colonic tissues using near-infrared Raman spectroscopy and support vector machines. , 2008, International journal of oncology.

[28]  Pool Jl The management of recurrent gliomas. , 1968 .

[29]  Christoph Krafft,et al.  Classification of malignant gliomas by infrared spectroscopy and linear discriminant analysis. , 2006, Biopolymers.

[30]  Hugh Barr,et al.  Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus , 2003, The Journal of pathology.

[31]  B. Haber,et al.  Endothelial growth factor present in tissue culture of CNS tumors. , 1976, Journal of neurosurgery.

[32]  P. Lasch,et al.  Spatial resolution in infrared microspectroscopic imaging of tissues. , 2006, Biochimica et biophysica acta.

[33]  A. Savitzky,et al.  Smoothing and Differentiation of Data by Simplified Least Squares Procedures. , 1964 .

[34]  Y. Ci,et al.  Fourier Transform Infrared Spectroscopic Characterization of Human Breast Tissue: Implications for Breast Cancer Diagnosis , 1999 .

[35]  N Ramanujam,et al.  Development of a multivariate statistical algorithm to analyze human cervical tissue fluorescence spectra acquired in vivo , 1996, Lasers in surgery and medicine.

[36]  P. Haris,et al.  Fourier transform infrared spectroscopy and differential scanning calorimetry of transferrins: human serum transferrin, rabbit serum transferrin and human lactoferrin. , 1994, Biochimica et biophysica acta.

[37]  R. Barnes,et al.  Standard Normal Variate Transformation and De-Trending of Near-Infrared Diffuse Reflectance Spectra , 1989 .

[38]  K. Bambery,et al.  A Fourier transform infrared microspectroscopic imaging investigation into an animal model exhibiting glioblastoma multiforme. , 2006, Biochimica et biophysica acta.

[39]  R. Salzer,et al.  Quantification of brain lipids by FTIR spectroscopy and partial least squares regression. , 2009, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[40]  Lutgarde M. C. Buydens,et al.  Strategy for constructing robust multivariate calibration models , 1999 .

[41]  R. Auer,et al.  Le Journal Canadien Des Sciences Neurologiques a Simple and Reproducible Experimental in Vivo Glioma Model , 2022 .